These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20807817)

  • 1. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.
    Ibrahim N; He L; Leong CO; Xing D; Karlan BY; Swisher EM; Rueda BR; Orsulic S; Ellisen LW
    Cancer Res; 2010 Sep; 70(18):7155-65. PubMed ID: 20807817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
    Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
    J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers.
    Leong CO; Vidnovic N; DeYoung MP; Sgroi D; Ellisen LW
    J Clin Invest; 2007 May; 117(5):1370-80. PubMed ID: 17446929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
    Zhang P; Liu SS; Ngan HY
    PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
    Bunch B; Krishnan N; Greenspan RD; Ramakrishnan S; Attwood K; Yan L; Qi Q; Wang D; Morrison C; Omilian A; Bshara W; Pili R; Trump DL; Johnson C; Woloszynska A
    Cell Cycle; 2019 Sep; 18(17):2055-2066. PubMed ID: 31318640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
    Swisher EM; Gonzalez RM; Taniguchi T; Garcia RL; Walsh T; Goff BA; Welcsh P
    Mol Cancer; 2009 Jul; 8():48. PubMed ID: 19602291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
    Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
    J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
    Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
    PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. deltaEF1 repressor controls selectively p53 family members during differentiation.
    Fontemaggi G; Gurtner A; Damalas A; Costanzo A; Higashi Y; Sacchi A; Strano S; Piaggio G; Blandino G
    Oncogene; 2005 Nov; 24(49):7273-80. PubMed ID: 16007124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
    Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
    FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulating p73 isoforms in human tumours.
    Coates PJ
    J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
    Vikhanskaya F; D'Incalci M; Broggini M
    Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
    Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
    Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
    Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
    Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
    John K; Alla V; Meier C; Pützer BM
    Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.